Atara linked the clinical hold to a lackluster FDA inspection of a third-party manufacturing facility, citing the CRL for Ebvallo it revealed last week. While drug product for ATA3219 is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback